GSK keeps top spot in 2012 sales
Published: 2013-04-12 07:00:00
Updated: 2013-04-12 07:00:00
GSK kept its number 1 ranking in terms of revenue last year from the leader board of multinational drug makers, but struggles this year against Novartis Korea which continued to overtake the top position, according to Yakup.com, a pharmaceutical information provider.
According to the data reco...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.